Inogen Correlations
INGN Stock | USD 11.95 0.58 4.63% |
The current 90-days correlation between Inogen Inc and Neuropace is 0.18 (i.e., Average diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Inogen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Inogen Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Inogen Correlation With Market
Average diversification
The correlation between Inogen Inc and DJI is 0.17 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Inogen Inc and DJI in the same portfolio, assuming nothing else is changed.
Inogen |
Moving together with Inogen Stock
0.74 | CAH | Cardinal Health | PairCorr |
0.68 | HQY | HealthEquity | PairCorr |
0.63 | MMSI | Merit Medical Systems | PairCorr |
0.67 | PRVA | Privia Health Group | PairCorr |
0.87 | ALHC | Alignment Healthcare LLC | PairCorr |
0.72 | TMCI | Treace Medical Concepts | PairCorr |
0.7 | CERT | Certara | PairCorr |
Moving against Inogen Stock
0.48 | HCAT | Health Catalyst | PairCorr |
0.4 | FLGC | Flora Growth Corp | PairCorr |
0.62 | LPTX | Leap Therapeutics | PairCorr |
0.56 | INZY | Inozyme Pharma | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Inogen Stock performing well and Inogen Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Inogen's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
NPCE | 3.82 | 1.36 | 0.36 | 1.98 | 2.85 | 9.73 | 35.79 | |||
SRDX | 0.75 | (0.11) | 0.00 | (1.77) | 0.00 | 1.68 | 9.34 | |||
LUNG | 2.98 | (0.07) | 0.00 | (0.11) | 0.00 | 8.44 | 20.44 | |||
APYX | 4.33 | 0.59 | 0.12 | 0.73 | 4.32 | 12.20 | 37.75 | |||
CVRX | 3.57 | 0.85 | 0.19 | 1.52 | 3.42 | 7.38 | 41.08 | |||
OFIX | 1.44 | 0.21 | 0.09 | 0.48 | 1.69 | 3.14 | 12.11 | |||
AORT | 1.37 | 0.23 | 0.10 | 0.75 | 1.38 | 3.49 | 9.51 | |||
HSKA | 1.18 | 0.61 | 0.88 | (3.74) | 0.00 | 3.63 | 21.36 | |||
KIDS | 2.48 | (0.13) | 0.00 | (0.04) | 0.00 | 4.85 | 16.22 | |||
SGHT | 2.80 | (0.76) | 0.00 | 2.74 | 0.00 | 6.65 | 17.90 |
Inogen Corporate Management
Nabil Shabshab | Pres CEO | Profile | |
Vijay Paliwal | Senior Enablement | Profile | |
Adrien Mithalal | Senior Development | Profile | |
Agnes Lee | VP Planning | Profile | |
Philip Corrin | Senior Chain | Profile |